Literature DB >> 3157273

[Roaccutan in acne and rosacea].

G Mahrle, K Bauermeister-Jasso, K Enderer.   

Abstract

Isotretinoin (Accutane) is a lately developed synthetic oral retinoid for treatment of severe forms of cystic acne resistant to therapy. Its pharmacological effect principally consists in decreased size of the sebaceous glands, reduced sebum production, as well as alteration of the bacterial micropopulation. At a dosage of 0.5 mg up to 1.0 mg/kg body weight daily, isotretinoin led to significant reduction of the inflammatory skin eruptions and long-lasting remission after discontinuation of the drug. With regard to 18 patients suffering from rosacea, the application of Accutane brought about satisfactory results, as well. Mucocutaneous side-effects were almost compulsory, but did never lead to discontinuation of the treatment. Because of its teratogenity, isotretinoin must not be applied in case of gravidity. Accutane offers new modes of therapy with respect to patients suffering from nodulocystic acne or severe rosacea which did not respond to common forms of treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157273

Source DB:  PubMed          Journal:  Z Hautkr        ISSN: 0301-0481


  2 in total

Review 1.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

Review 2.  Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.

Authors:  Jasper C A Broen; Jacob M van Laar
Journal:  Nat Rev Rheumatol       Date:  2020-02-13       Impact factor: 20.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.